CXW · CoreCivic, Inc.

Current Thesis

The leg being bought is not "more detainees" — it is a financing mechanism that is roughly two months old. The Department of Homeland Security has begun buying CoreCivic's detention real estate outright while CoreCivic keeps the operating contract. The 2026-08-05 second-quarter release put four facilities sold at $2.2 billion gross, about $307,000 per bed, producing a gain of roughly $1.8 billion; the two most recent — the 1,600-bed Prairie Correctional Facility in Minnesota and the 1,033-bed Midwest Regional Reception Center in Kansas — Proceeds went straight into the capital structure: $608.5 million of debt repaid, total debt expected around $739.1 million after the August repayments, and a repurchase authorization expanded by $500 million with $755.8 million remaining.

The narrative is accelerating — the sale-and-keep-operating structure first appeared in July 2026, two more closed on 2026-08-06, and management said on the 2026-08-05 release that discussions with ICE about acquiring additional facilities are preliminary with no assurance of further sales, which means the next data point is genuinely new information rather than a re-run of a known story. Shares closed 2026-09-04 at $34.71, level with the 52-week high, after a 40.4% three-month advance, with RSI(14) at 56.4 — a new high made without momentum extension.

Bullish and bearish views on CoreCivic, Inc.

The model's bull view on CoreCivic, Inc. (CXW), in brief: Q2 2026 revenue $684.9 million, up 27.3% year over year (release 2026-08-05); occupancy 78.4% versus 76.8% in Q2 2025, so there is still unfilled capacity behind the revenue line. The bear view: Operating leverage is thin against the revenue optics: Q2 2026 revenue grew 27.3% while adjusted EBITDA rose only 5.9% to $109.4 million and net income fell 3.6% to $37.1 million. Both cases follow in full.

Bull Case

• Q2 2026 revenue $684.9 million, up 27.3% year over year (release 2026-08-05); occupancy 78.4% versus 76.8% in Q2 2025, so there is still unfilled capacity behind the revenue line.
• ICE revenue rose $78.2 million year over year in the quarter and represented roughly 53% of residential-segment revenue (2026-08-05 release) — the federal counterparty is now the majority of the operating business.
• ICE populations in CoreCivic's care rose about 6,000, or 59.6%, from the start of 2025 through 2026-06-30, with five previously idle facilities activated under new ICE management contracts (Q2 2026 materials).
• Full-year 2026 guidance was raised on 2026-08-05: adjusted diluted EPS $1.62–1.70, adjusted EBITDA $440.5–445.5 million, normalized FFO per share $2.61–2.70.
• Dated contract backlog: the 2,560-bed California City Immigration Processing Center runs through August 2027 at roughly $130 million of annual revenue; the 2,160-bed Diamondback facility in Oklahoma commenced 2025-09-30 at approximately $100 million annually once fully activated.
• Sell-side moved with the print: Benchmark raised its target to $45 on 2026-08-07 and Jones Trading to $42 on 2026-08-06, both at Buy — both above the 2026-09-04 close of $34.71.

Bear Case

• Operating leverage is thin against the revenue optics: Q2 2026 revenue grew 27.3% while adjusted EBITDA rose only 5.9% to $109.4 million and net income fell 3.6% to $37.1 million. Activating idle facilities costs money before it earns it.
• The headline FY26 guide of $15.00–15.20 diluted EPS is dominated by the roughly $1.8 billion sale gain. The recurring figure is $1.62–1.70 adjusted; anyone screening on GAAP EPS is looking at a one-time item.
• Officers sold into the advance: per SEC Form 4 filings, CFO David Garfinkle sold 50,000 shares at a weighted average $33.96 on 2026-08-21, EVP Lucibeth Mayberry 120,000 shares at $33.29 on 2026-08-12, and EVP Anthony Grande 29,199 shares on 2026-08-17 — three officers, all inside a two-week band just under the 2026-09-04 high.
• Selling the buildings removes the owned-asset floor under the earnings. What remains at those four sites is a management contract with a single counterparty whose funding is set annually by appropriation.
• No company-dated catalyst falls between 2026-09-05 and 2026-10-05, so the advance has to be carried by flow and headlines rather than by a print.

Setup & Price Structure

The 2026-09-04 close of $34.71 is the 52-week high, which means there is no overhead supply from the prior twelve months and no prior failed breakout to reference. RSI(14) at 56.4 alongside that high is the structure of a grind, not a blow-off — the stock has been making highs without stretching momentum, consistent with a three-month gain of 40.4% that was accumulated rather than gapped.

The usable shelf sits just underneath: the August officer sales printed at weighted averages of $33.29 and $33.96, and the post-print consolidation held above that band into September. Below it there is no defined base until the pre-August range. Weekly closes above $31 keep the summer advance structurally intact; a weekly close under it puts the shares back inside a zone the market has not tested since the guidance raise. The analyst band of $42–45 sits well above spot, so the sell-side target structure is not the constraint here — appropriations and contract-award flow is.

Catalyst Calendar (next 30 days)

• 2026-09-05 to 2026-10-05: no confirmed company-scheduled event. This window is empty of prints, and that is itself a condition of the read.
• 2026-09-30: US federal fiscal year end. ICE award activity has historically clustered at this boundary — the Diamondback contract commenced 2025-09-30 — so new-award headlines, if they come, are most likely dated here.
• Ongoing: ICE's periodically updated detention population statistics. Population is the variable that converts CoreCivic's activated capacity into revenue; occupancy was 78.4% at Q2.
• ~2026-11-04 (est.): Q3 2026 results. Q3 2025 was reported 2025-11-05.
• 2026-11-03: US midterm elections, which set the congressional stance on FY2027–28 detention appropriations.

What Would Change Our Mind

The first thing that breaks is the facility-sale mechanism. If the ICE purchase discussions described as preliminary on 2026-08-05 produce nothing by the Q3 print around 2026-11-04, the story reverts to organic population growth on 78.4% occupancy — a slower, more ordinary business, and one where Q2's pattern of 27.3% revenue growth converting into a 3.6% net income decline becomes the governing fact rather than a transition cost.

On the tape, a weekly close below $31 breaks the summer structure: it loses the August consolidation band where three officers filed sales at $33.29–$33.96 and cuts back into the range that preceded the 2026-08-05 guidance raise. A second condition would be 2027 adjusted EBITDA guidance issued below the 2026 exit rate of $440.5–445.5 million, which would say the activations are not scaling. A third would be the theme turning saturated — mainstream coverage of the detention buildout arriving without a widening bid, visible as new highs on falling volume into the November print.

Correlation Notes

• No theme cluster in the current registry carries this name, so this reads as a single-name setup rather than a group move; nothing here depends on a cohort re-rating.
• The closest listed comparable is GEO Group, the other US private detention operator. Both track ICE contracting and appropriations headlines rather than the broad index, and a policy headline hits them together.
• Because the company guides on FFO per share ($2.59–2.68 FFO, $2.61–2.70 normalized for 2026) it screens against real-estate names, but the 2026 asset sales cut the owned-property base — the correlation that matters now runs to the federal budget calendar, not to rates.
• Counterparty concentration is the dominant factor: with ICE at roughly 53% of residential-segment revenue in Q2 2026, the stock's sensitivity is to DHS funding decisions before it is to anything else.